Gyre Therapeutics GYRE Cash Flow Statement (2010-2026)

NASDAQ GYRE
$6.86 +0.42 (+6.52%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Gyre Therapeutics Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Gyre Therapeutics reported cash from operations of -$16.75M and free cash flow of -$17.01M for the quarter ended Jun 2026, down 124.1% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-25.24M-20.31M-14.54M51.63M-4.88M-28.79M4.22M3.77M7.51M-101.81M9.94M4.54M2.86M-0.43M3.73M-2.24M5.94M2.72M-9.86M-14.27M
Share-based CompensationStock Comp.
3.04M0.68M2.94M3.01M12.76M12.28M25.52M25.52M25.52M6.88M18.22M18.10M18.55M1.75M17.76M17.81M18.04M4.60M19.64M19.55M
Deferred Taxes
-0.33M-0.23M-0.20M-0.40M-0.31M-0.10M-0.59M-0.19M-0.30M-0.53M-0.09M-0.74M-1.43M
Gains from Investment SecuritiesGains Investment
-4.29M-2.91M0.23M-0.19M-2.25M-0.21M0.02M-0.26M-0.09M
Asset Writedowns and ImpairmentWritedown
0.20M
Cash from OperationsCash from Ops.
-21.60M-17.68M-12.05M-12.29M-7.28M42.30M10.42M4.53M7.58M3.36M2.88M-5.49M1.73M-2.76M-0.13M-7.47M14.24M-5.62M3.20M-16.75M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
Depreciation & Amortization (CF)Dep. & Amort.
0.09M0.12M0.11M0.07M0.04M0.87M0.28M0.31M0.19M0.30M0.41M0.23M0.45M0.46M0.54M1.01M0.28M0.66M0.67M1.48M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.86M0.70M-1.05M-0.56M1.15M0.72M4.24M1.01M4.83M-8.57M4.47M
Change in InventoryChange Inventory
-0.53M-0.12M-0.92M-0.18M0.67M0.72M0.64M0.12M1.54M0.95M-0.07M1.21M1.01M-0.09M
Change in Account PayablesChange Payables
2.03M2.56M-1.71M-3.67M-1.00M6.27M0.16M0.37M0.00M-0.10M-0.02M-0.06M0.03M-0.19M0.01M0.44M-0.01M-0.43M0.14M4.66M
Change in Accured ExpensesChange Accured Exp.
0.81M-5.15M1.04M-4.72M-0.64M6.23M1.03M1.93M-3.00M1.49M-1.97M-0.07M-1.55M2.09M4.44M-2.02M-3.86M2.38M0.68M-0.50M
Change in TaxesChange Taxes
1.92M-1.23M2.50M-0.18M1.42M-4.19M0.54M0.07M-2.27M0.51M1.54M0.26M0.14M-1.02M
Other Working Capital ChangesOther WC Changes
-1.19M-0.62M-0.23M
Investing Activities
Capital ExpendituresCapex
0.49M1.74M2.48M1.97M2.32M0.23M1.46M0.69M-0.07M0.12M0.34M0.59M0.14M0.18M0.26M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.05M0.36M0.17M0.05M0.22M-0.01M0.14M0.00M0.02M0.01M0.01M0.01M
Change in IntangiblesChange Intangibless
1.00M
Change in Acquisitions & DivestmentsChange Acquisitions
7.53M2.87M2.50M11.19M12.00M-12.00M4.24M10.07M3.00M
Cash from Investing ActivitiesCash from Investing
7.04M2.87M2.50M52.87M-69.19M-7.65M-8.05M-5.40M1.34M-7.22M-8.27M-2.39M-2.00M1.97M1.35M-5.64M1.85M-3.06M9.76M
Financing Activities
Other financing activitiesOther financing
0.66M0.28M0.37M0.59M0.96M1.03M0.05M0.36M0.02M0.20M
Cash from Financing ActivitiesCash from Financing
0.10M0.02M-45.03M-7.76M-3.50M-1.48M15.24M0.66M0.16M0.32M0.96M1.34M20.25M2.47M0.32M0.02M-0.01M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
1.49M0.88M0.84M0.00M0.68M0.95M3.85M0.21M
Net Equity Issued and RepurchasedNet Equity Issued
0.51M22.49M1.28M0.50M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
7.76M3.50M1.50M
Additional items
Exchange Rate EffectFX Effect
0.20M-0.90M0.17M0.23M-0.05M-0.08M0.11M-0.26M0.05M-0.04M0.21M0.13M0.28M0.64M
Change in Cash
-14.46M-14.81M-9.53M40.58M-52.30M16.23M2.97M-4.42M2.35M7.43M-3.72M-13.69M-0.23M-4.05M3.23M14.09M11.27M-3.33M0.43M-6.34M
Free Cash FlowFCF
-22.09M-17.68M-12.05M-12.29M-7.28M42.30M8.68M2.06M5.61M1.04M2.65M-6.95M1.03M-2.69M-0.25M-7.81M13.65M-5.77M3.02M-17.01M
Net Cash FlowNCF
-14.46M-14.81M-9.53M40.58M-52.30M-26.89M-4.99M-7.02M0.70M19.94M-3.68M-13.61M-0.34M-3.80M3.18M14.12M11.07M-3.46M0.17M-7.00M